ESPEN 2013: BIA completely accepted by nutritionists

Bioelectrical Impedance Analysis (BIA) is a topical issue in nutrition medicine. That was made clear by the crowds at the seca BIA Workshop “Bioelectrical Impedance Analysis in Malnutrition and Obesity: Meet the Experts” at ESPEN in Leipzig. Nutritionists were eager to hear research results and information about clinical application of BIA directly from the experts. The list of speakers read like a Who’s Who of researchers working in body composition analysis with BIA. All seats in the auditorium were quickly filled, leaving standing-room only for the overflow crowd of 50.

Dr. Anja Bosy-Westphal, (professor at the Institute for Nutrition at the University of Hohenheim, Hohenheim, Germany) spoke about the benefits of using BIA in the treatment of overweight patients. She explained how BIA raw data such as the phase angle and Bioelectric Impedance Vector Analysis are applied to body composition estimate in cases of obesity.
In her lecture, Dr. Kristina Norman (nutritionist in the Department of Gastroenterology, Infectiology and Rheumatology, Charité Universitätsmedizin Berlin, Germany) covered the applicability of BIA for malnourished patients. The BIVA in particular, she said, delivers valuable information for detection of malnutrition caused by disease and helps with monitoring patients’ nutritional therapy.
None other than Dr. Manfred J. Müller (professor and head of the Institute of Human Nutrition and Food Science, Christian-Albrechts-University in Kiel/Germany) and Dr. Marinos Elia (professor at the Institute of Human Nutrition and Faculty of Medicine, University of Southampton, Southampton General Hospital, Great Britain) co-chaired the workshop and led the lively follow-up discussion.

seca mBCA – developed for medical use
The seca BIA Workshop was organized by seca to underscore the significance of BIA in clinical practice. Martin Höfler, team leader of seca Product Management, knows how important BIA is: “The information gained from BIA in the diagnosis and treatment of nutrition-related diseases is now recognized around the world. In addition to its use in nutrition, body composition analysis made with BIA will also have an influence on diabetology and nephrology.”
The medical Body Composition Analyzer seca mBCA 515 features state-of-the-art technology for body composition analysis. The innovative device achieves unmatched medical precision, according to international studies* in which the technology was validated against medical gold standards. The seca mBCA is intuitively operated and specially designed for working conditions in medical practice. The integrated electrodes on the device’s railing, for example, prevent measurement errors and ensure reproducible results. The seca mBCA can be easily integrated into the seca 360° wireless system and into computer networks in medical practices and hospitals.

*Current status: www.seca.com/studies
For more information on the seca mBCA, visit: mbca.seca.com

Since its founding in 1840 seca has proven its skill at developing innovative weighing technology combined with practical functions. Today seca is the world market leader in medical measuring and weighing. seca’s distribution network expands into 110 countries, in addition to the seca headquarter in Germany there are ten distribution subsidiaries in countries throughout the world. seca scales and measuring instruments are sold exclusively through specialized medical dealers. The worldwide seca service network guarantees continuous maintenance of the precision instruments.

seca gmbh & co. kg
Hammer Steindamm 9-25
22089 Hamburg, Germany
Phone +49 40 2000000
media.de@seca.om

This release was published on openPR.